On the whole, cross-reactions hitting adiponectin might lead to obesity, metabolic syndrome, diabetes, endothelial dysfunction, atherosclerosis, hypertension, and coronary artery disease [52]. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.